The largest database of trusted experimental protocols

8 protocols using cd62l pe

1

Isolation and Phenotyping of Immune Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Mononuclear cells from liver and spleen and stromal vascular cells (SVC) from AT (epididymal and perirenal depots) were isolated as described previously (Stefanovic‐Racic et al. 2012). Cell suspensions (2 × 106 cells/sample) were preincubated with anti‐CD16/32 (Fc “blocking” antibodies [Abs]) for 15 min at 4°C, then stained with either fluorescent‐labeled Abs or IgG isotype controls for 30 min at 4°C. The following Abs were used: CD8/PerCP and CD45/PerCP (BD Biosciences, San Jose, CA), CD4/FITC, CD62L/PE, NK1.1/PeCy7, B220/v450, CD3/APC, CD86/FITC, MHC2/PE, CD11b/PeCy7, B220/v450, CD11c/APC, and F4/80/Alexa780 (eBiosciences, San Diego, CA). Following incubation with Abs, liver and AT cells were incubated in Aquaporin dye (Invitrogen, Grand Island, NY) for 15 min, to distinguish live from dead cells, then fixed in 4% paraformaldehyde (Fisher, Waltham, MA) before being analyzed using a FACSCalibur flow cytometer and FACSDiva software (BD Biosciences). A proportion of up to 1% false‐positive events were accepted in the isotype control samples.
+ Open protocol
+ Expand
2

Stimulation and Intracellular Cytokine Analysis of T-cell Subsets

Check if the same lab product or an alternative is used in the 5 most similar protocols
Freshly isolated PBMCs (Day 0) and the expanded VSTs (Day 8) were resuspended at 1.0 × 106 cells per mL−1 and plated in 96 well plates (200 μL per well). The cells were then stimulated with 50 ng of PHA (positive control), RPMI alone (negative control) or viral peptides for 1 hour at 37 °C and for a subsequent 4 hours at 37 °C in presence of Brefeldin A (1 μg/mL). Following incubation, PBMCs and the expanded VSTs were washed twice with PBS and surface stained for 45 minutes with CD45RA FITC, CD62L PE and CD8 PerCP (ebioscience, San Diego, CA, USA) mAbs. The cells were then washed once more in PBS and fixed overnight at 4 °C in 4% Paraformaldehyde (Sigma Aldrich, St Louis, MO, USA). Excess fixating agent was washed off twice with permeabilization buffer (PBS+0.2% saponin) and cells were incubated for 45 minutes in permeabilization buffer and an anti-TNF-α mAb conjugated to APC (ebioscience, San Diego, CA, USA). Intracellular expression of TNF-α by the different T-cell subsets with and without peptide stimulation was analyzed on a BD accuri C6 flow cytometer.
+ Open protocol
+ Expand
3

Multicolor Flow Cytometry Panel

Check if the same lab product or an alternative is used in the 5 most similar protocols
Commercial antibodies (clones, fluorophores and sources) are as follows: CD3-FITC (145–2C11), CD62L-PE (Mel-14), CD4-PErCP/Cy5.5 (RM4–5), CD8-PerCP/Cy5.5 (53–6.7), CD8-APC (53–6.7), CD209b-APC (22D1), IgM-FITC (II/41), CD4-PE (GK1.5), CD25-AF488 (PC61.5), Streptavidin-PE, CD169-PE/Cy7 (3D6.112) (eBioscience, San Diego, CA); CD11b-FITC (M1/70), CD49d-FITC (R1–2), TCRβ-FITC (GL3), CD21/35-PE (7E9), CD23-APC (B3B4), Ly6G-PE (RB6–8C5), Ly6C-PerCP/Cy5.5 (HK1.4), CD11c-PE/Cy7 (N418), B220-PerCP/Cy5.5 (RA3–6B2), B220-APC (RA3–6B2), B220-APC/Cy7 (RA3–6B2), CD69-BV421 (H1.2F3),CD23-Biotin (B3B4), F4/80-APC (BM8), Ly6G-BV421 (1A8), CD45-Pacific Blue (30-F11), CD45-BV510 (30-F11), CD43-PE (1B11), CD24-PE/Cy7 (M1/69), IgD-Pacific Blue (11–26c.2a), CD69-PE/Cy7 (H1.2F3), IgD-PerCP/Cy5.5 (11–26c.2a), Ly51-AF647 (6C3), CD3-Pacific Blue (17A2), CD3-PE (17A2), TCRγ/δ-biotin (GL3), Streptavidin-PE/Cy7 (Biolegend, San Diego, CA); Siglec-F-PE (E50–2440) (BD Biosciences, San Jose, CA). Samples were preincubated with 1 μg Fc-block (2.4G2 hybridoma; ATCC).
Cells were acquired either on the BD Biosciences LSR Fortessa or with a BD FACScan flow cytometer with DxP multi-color upgrades by Cytek Development Inc. (Woodland Park, NJ) and analyzed using FlowJo software (FlowJo LLC, Ashland, OR).
+ Open protocol
+ Expand
4

Flow Cytometric Immunophenotyping and ATP Detection

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cell suspensions were stained with the following antibodies: CD4-FITC (1 μg/ml), CD8-APC (0.4 μg/ml), CD62L-PE (0.4 μg/ml), CD69-PE (0.4 μg/ml) (all from e-Bioscience, Frankfurt, Germany), and CD49e-PE (0.4 μg/ml) (Biolegend, Fell, Germany) and analyzed by flow cytometry. For detection of ATP, draining LNs were removed from sensitized mice, disrupted with tweezers, and assayed for ATP (ATPlite, Perkin Elmer). For DC–T-cell co-cultures, DCs were prepared as previously described (Ring et al., 2010b (link)). Co-cultures of 1 × 106 T cells and 1 × 105 DCs or 5 × 104 DCs were set up in 1 ml complete medium, and tissue culture supernatant was assessed for IL-10 and IFN-γ by ELISA (Ready-SET-Go, eBioscience, Frankfurt, Germany).
+ Open protocol
+ Expand
5

Phenotyping T-cell Subsets by Flow Cytometry

Check if the same lab product or an alternative is used in the 5 most similar protocols
Freshly isolated PBMCs and the expanded VSTs (1.0 × 106) were labeled with pre-diluted monoclonal antibodies (mAbs) in a 4-color direct immunofluorescence assay. Cells were incubated at room temperature in the dark for 45-minutes. The mAb combinations consisted of CD45RA FITC, CD62L PE, CD4 PerCP or CD8 PerCP and CD3 APC (ebioscience, San Diego, CA, USA). This allowed for the determination of naïve (NA; CD45RA+/CD62L+), central memory (CM; CD45RA−/CD62L+), effector memory (EM; CD45RA−/CD62L−) and CD45RA+ EM (EMRA; CD45RA+/CD62L−) subsets within the CD4+ and CD8+ T-cells29 (link)30 (link) before and after expansion. The phenotypes of the freshly isolated PBMCs (Day 0) and the expanded VSTs (Day 8) were assessed on a BD Accuri C6 flow cytometer (Accuri, Ann Arbor, MI, USA) as previously described22 (link). The total number of T-cell subsets in blood before and after exercise was determined by multiplying the percentage of cells staining positive for the appropriate surface markers in the flow cytometry lymphocyte gate by the total blood lymphocyte count (Table 2).
+ Open protocol
+ Expand
6

Naïve CD4+ T Cell Transfer Colitis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Naïve CD4+ T cell were isolated from C57BL/6 (CD45.1) mouse spleens and lymph nodes with a mouse CD4+ T cell isolation kit as per the manufacturer's instructions (Stemcell Technology, Canada). The isolated CD4+ T population was labeled with CD45Rb-FITC, CD62L-PE, and CD4-APC (eBiosciences, San Diego, CA). CD4+CD62L+CD45RBhi T cells were sorted by flow cytometry. Then 3.5 × 105 cells were injected into RAG1−/− mice by intraperitoneal (IP) injection. Mouse body condition, the form of their stool and weight were monitored at least weekly. Mice started to lose weight and develop looser stools around 3–4 weeks in our facility indicating that colitis was present.
+ Open protocol
+ Expand
7

Lymphocyte Immunophenotyping by Flow Cytometry

Check if the same lab product or an alternative is used in the 5 most similar protocols
Lymphocyte stainings were performed by incubation for 20 min on ice using conjugated the following mAbs (eBioscience, San Diego, CA, USA): CD8-FITC (#11-0081-82), CD4-FITC(#MCD0401), CXCR3-APC (#17-1831-82), CCR5-PE (#12-1951-81), CD62L-PE (#12-0621-81), CD44-APC (#17-0441-81), CD25-APC (#17-0251-82), B220 FITC (#11-0452-82), CD5-PE (#12-0051-82), CD23-APC (#MCD2305).
+ Open protocol
+ Expand
8

Neutrophil Surface Marker Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Surface activation markers and cell viability markers in blood derived human neutrophils were analyzed using Flow Cytometry analyzer of either the BD LSR II or the BD LSR Fortessa series (Becton Dickinson) and analyzed with FlowJo software (Tree Star). The following antibodies were used: Anti-human: CD15-APC, CD62L-PErCP-efluor710, CD66b-PE-Cy7. Anti-mouse: Ly6G(1A8)-APC-Cy7, CD62L-PE, CD11b-PE-Cy7 (all from e-Bioscience). Cell viability: Live/Dead fixable Aqua Dead Cell Stain Kit (Invitrogen).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!